Latest Breaking News On - Gain therapeutics inc - Page 9 : comparemela.com

Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research

BETHESDA, Md., Dec. 04, 2023 Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today.

John vandermostenMatthias alderSusan sharpeLinnden communicationsGain therapeutics incFamily officeCap researchChief executive officerSenior analystZacks small cap researchGain therapeuticsMedia contact

Gain Therapeutics (GANX) Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Allosteric Regulators in GM1 Gangliosidosis Model

Gain Therapeutics (GANX) Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Allosteric Regulators in GM1 Gangliosidosis Model
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Maurizio molinariInstitute for researchGain therapeutics incQuality control group leaderGain therapeuticsProtein foldingSite directed enzyme enhancement therapyManolo bellottoChief strategy officerGeneral manager

Gain Therapeutics Announces Closing of $10 1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

Gain Therapeutics Announces Closing of $10 1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Boca ratonSusan sharpeEquity syndicate departmentGain therapeutics incLinnden communicationsCompany nasdaqAllele capital partnersCompany formGlobenewswire incNewbridge securities corporationExchange commissionSecurities corporationCapital partnersFinancial advisorSyndicate departmentFederal highway

Gain Therapeutics Announces Closing of $10 1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

BETHESDA, Md., Nov. 24, 2023 Gain Therapeutics, Inc. today announced the closing of an underwritten public offering of 2,545,000 shares of its common stock and warrants to purchase up to an.

Boca ratonSusan sharpeEquity syndicate departmentGain therapeutics incLinnden communicationsCompany nasdaqAllele capital partnersCompany formExchange commissionNewbridge securities corporationSecurities corporationCapital partnersFinancial advisorFederal highwaySecurities actGain therapeutics

Gain Therapeutics Announces Closing of $10 1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

Gain Therapeutics Announces Closing of $10 1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Boca ratonSusan sharpeLinnden communicationsCompany formExchange commissionAllele capital partnersEquity syndicate departmentCompany nasdaqNewbridge securities corporationGain therapeutics incGain therapeuticsSecurities corporationCapital partnersFinancial advisorFederal highwaySecurities act